Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes: A Real World Observational Study of Available Systems
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2026-12 · 66 (6)
DOI: 10.1111/ajo.70198 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, online erschienen am 05.11.2026. Verfasst von Stephanie L Teasdale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Obstetric Medicine Department, Mater Mothers Hospital, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Pregnancy in Diabetics, Insulin, Insulin Infusion Systems. Die Arbeit nennt 12 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Only one automated insulin delivery (AID) system is licensed in Australia for use in pregnancies complicated by Type 1 diabetes (T1D); however, some women using other AID systems have continued to use these ‘off‐label’ in pregnancy. Usage patterns from a single centre in Australia will be of interest to clinicians supporting women with T1D in pregnancy.
Aims
This is an observational study evaluating outcomes in women treated with different AID systems through a pregnancy cared for at a tertiary maternity centre. Materials and Methods All women using AID in one or more trimesters of pregnancy through a 3‐year study period are included in the reporting of glycaemic and insulin delivery measures in each trimester of pregnancy. All women using AID throughout the duration of a pregnancy within the study period are included in the reporting of birth outcomes.
Results
Four AID systems had been used during the study period, MiniMed with Smartguard, T:slim with Control IQ, YpsoMed with CamAPS and Omnipod with SmartAdjust. Small numbers of YpsoMed and Omnipod users precluded these from statistical analysis. Women using MiniMed and T:slim AID systems differed in terms of early HbA1c and smoking history with MiniMed users representing suboptimal pre‐pregnancy diabetes control. Use of continuous glucose monitoring (CGM) was additionally significantly lower for users of the MiniMed system. Median pregnancy‐specific time in range (pTIR) was above 62% for all systems by trimester 2 and above 64% for all systems by trimester 3 with no significant difference between MiniMed and T:slim systems. There was less pregnancy‐specific time below range (pTBR) and/or time well below range (pTWBR) for the MiniMed system in all trimesters compared with the T:slim system.
Conclusions
AID systems without the tight target considered necessary for pregnancy were still able to achieve good glycaemic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obstetric Medicine Department, Mater Mothers Hospital, Brisbane, Queensland, Australia.
ORCID-Profile: Stephanie L Teasdale, Julian Pavey, Melissa Lee, Janelle C Nisbet
Zitieren
APA
Teasdale, S. L., Pavey, J., Lee, M., & Nisbet, J. C. (2026). Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes: A Real World Observational Study of Available Systems. Australian and New Zealand Journal of Obstetrics and Gynaecology, 66(6). https://doi.org/10.1111/ajo.70198
Vancouver
Teasdale SL, Pavey J, Lee M, Nisbet JC. Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes: A Real World Observational Study of Available Systems. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2026;66(6). doi:10.1111/ajo.70198
BibTeX
@article{Teasdale2026,
author = {Teasdale, Stephanie L and Pavey, Julian and Lee, Melissa and Nisbet, Janelle C},
title = {Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes: A Real World Observational Study of Available Systems},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2026},
volume = {66},
number = {6},
doi = {10.1111/ajo.70198}
}
EUVIMED